Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients

Ilkka Rauma; Tiina Mustonen; Juha Matti Seppä; Maritta Ukkonen; Marianne Mannikko; Auli Verkkoniemi-Ahola; Marge Kartau; Jukka T. Saarinen; Liisa Luostarinen; Sakari Simula; Mervi Ryytty; Riitta Ahmasalo; Jussi O. T. Sipilä; Ilkka Pieninkeroinen; Tero Tapiola; Anne M. Remes; Hanna Kuusisto

doi:10.1007/s00415-021-10664-w

Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients

Ilkka Rauma, Tiina Mustonen, Juha Matti Seppä, Maritta Ukkonen, Marianne Mannikko, Auli Verkkoniemi-Ahola, Marge Kartau, Jukka T. Saarinen, Liisa Luostarinen, Sakari Simula, Mervi Ryytty, Riitta Ahmasalo, Jussi O. T. Sipilä, Ilkka Pieninkeroinen, Tero Tapiola, Anne M. Remes, Hanna Kuusisto

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	Journal of Neurology
Volym	269
Nummer	2
Sidor (från-till)	824-835
Antal sidor	12
ISSN	0340-5354
DOI	https://doi.org/10.1007/s00415-021-10664-w
Status	Publicerad - feb. 2022
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3112 Neurovetenskaper
3124 Neurologi och psykiatri

Åtkomst av dokument

10.1007/s00415-021-10664-w

Rauma2022_Article_SafetyOfAlemtuzumabInANationwiSlutlig publicerad version, 896 KBLicens: CC BY

Citera det här

Rauma, I., Mustonen, T., Seppä, J. M., Ukkonen, M., Mannikko, M., Verkkoniemi-Ahola, A., Kartau, M., Saarinen, J. T., Luostarinen, L., Simula, S., Ryytty, M., Ahmasalo, R., Sipilä, J. O. T., Pieninkeroinen, I., Tapiola, T., Remes, A. M., & Kuusisto, H. (2022). Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients. Journal of Neurology, 269(2), 824-835. https://doi.org/10.1007/s00415-021-10664-w

@article{dad1efc2c5d84d2cb212bacc78f46d91,

title = "Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients",

keywords = "Alemtuzumab, Autoimmunity, Drug-related side effects and adverse reactions, Incidence, Multiple sclerosis, Safety, AUTOIMMUNE-DISEASE, FOLLOW-UP, EFFICACY, THERAPY, TYPE-1, 3112 Neurosciences, 3124 Neurology and psychiatry",

author = "Ilkka Rauma and Tiina Mustonen and Sepp{\"a}, {Juha Matti} and Maritta Ukkonen and Marianne Mannikko and Auli Verkkoniemi-Ahola and Marge Kartau and Saarinen, {Jukka T.} and Liisa Luostarinen and Sakari Simula and Mervi Ryytty and Riitta Ahmasalo and Sipil{\"a}, {Jussi O. T.} and Ilkka Pieninkeroinen and Tero Tapiola and Remes, {Anne M.} and Hanna Kuusisto",

year = "2022",

month = feb,

doi = "10.1007/s00415-021-10664-w",

language = "English",

volume = "269",

pages = "824--835",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "2",

}

Rauma, I, Mustonen, T, Seppä, JM, Ukkonen, M, Mannikko, M, Verkkoniemi-Ahola, A, Kartau, M, Saarinen, JT, Luostarinen, L, Simula, S, Ryytty, M, Ahmasalo, R, Sipilä, JOT, Pieninkeroinen, I, Tapiola, T, Remes, AM & Kuusisto, H 2022, 'Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients', Journal of Neurology, vol. 269, nr. 2, s. 824-835. https://doi.org/10.1007/s00415-021-10664-w

TY - JOUR

T1 - Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients

AU - Rauma, Ilkka

AU - Mustonen, Tiina

AU - Seppä, Juha Matti

AU - Ukkonen, Maritta

AU - Mannikko, Marianne

AU - Verkkoniemi-Ahola, Auli

AU - Kartau, Marge

AU - Saarinen, Jukka T.

AU - Luostarinen, Liisa

AU - Simula, Sakari

AU - Ryytty, Mervi

AU - Ahmasalo, Riitta

AU - Sipilä, Jussi O. T.

AU - Pieninkeroinen, Ilkka

AU - Tapiola, Tero

AU - Remes, Anne M.

AU - Kuusisto, Hanna

PY - 2022/2

Y1 - 2022/2

KW - Alemtuzumab

KW - Autoimmunity

KW - Drug-related side effects and adverse reactions

KW - Incidence

KW - Multiple sclerosis

KW - Safety

KW - AUTOIMMUNE-DISEASE

KW - FOLLOW-UP

KW - EFFICACY

KW - THERAPY

KW - TYPE-1

KW - 3112 Neurosciences

KW - 3124 Neurology and psychiatry

U2 - 10.1007/s00415-021-10664-w

DO - 10.1007/s00415-021-10664-w

M3 - Article

SN - 0340-5354

VL - 269

SP - 824

EP - 835

JO - Journal of Neurology

JF - Journal of Neurology

IS - 2

ER -